The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Calindol ID: ALA1801356
Max Phase: Preclinical
Molecular Formula: C21H20N2
Molecular Weight: 300.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Synonyms: Calindol
Canonical SMILES: C[C@@H](NCc1cc2ccccc2[nH]1)c1cccc2ccccc12
Standard InChI: InChI=1S/C21H20N2/c1-15(19-11-6-9-16-7-2-4-10-20(16)19)22-14-18-13-17-8-3-5-12-21(17)23-18/h2-13,15,22-23H,14H2,1H3/t15-/m1/s1
Standard InChI Key: JLPWXRZETODYFC-OAHLLOKOSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
-2.2076 4.1153 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1366 3.3126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8846 2.9749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7144 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0097 4.2994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4302 3.5910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4255 2.0688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.7112 1.6521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4223 2.8958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4388 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4388 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4076 5.0263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2590 3.5923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7144 -0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7144 -0.8251 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1372 1.9803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4288 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.2450 5.0327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6655 4.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4288 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
1 5 1 0
4 6 2 0
3 7 1 0
5 7 2 0
4 9 1 0
8 9 1 0
2 10 1 0
8 10 1 0
6 11 1 0
4 12 1 0
6 13 1 0
12 14 2 0
5 15 1 0
7 16 1 0
11 17 2 0
14 17 1 0
11 18 1 0
9 19 1 6
13 20 2 0
15 21 2 0
16 22 2 0
21 22 1 0
18 23 2 0
20 23 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 300.41Molecular Weight (Monoisotopic): 300.1626AlogP: 5.17#Rotatable Bonds: 4Polar Surface Area: 27.82Molecular Species: BASEHBA: 1HBD: 2#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 8.87CX LogP: 4.68CX LogD: 3.20Aromatic Rings: 4Heavy Atoms: 23QED Weighted: 0.53Np Likeness Score: -0.79
References 1. Kiefer L, Gorojankina T, Dauban P, Faure H, Ruat M, Dodd RH.. (2010) Design and synthesis of cyclic sulfonamides and sulfamates as new calcium sensing receptor agonists., 20 (24): [PMID:21041081 ] [10.1016/j.bmcl.2010.10.006 ] 2. Kiefer L, Beaumard F, Gorojankina T, Faure H, Ruat M, Dodd RH.. (2016) Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists., 24 (4): [PMID:26752095 ] [10.1016/j.bmc.2015.12.019 ]